Skip to Main Content

China has never unconditionally approved an innovative drug that was discovered and developed by its own scientists for a common oncology indication. Nor has it exported a homegrown drug to the wider world in the modern era.

A Chinese drug maker known as Chi-Med could cross the finish line first in both those categories. Here’s what you need to know about the company, its lead cancer drug, and its path forward.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.